4.1 Article

Psychiatric Disorders and Sleep

Journal

NEUROLOGIC CLINICS
Volume 30, Issue 4, Pages 1389-+

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.ncl.2012.08.018

Keywords

Psychiatric disorders; Sleep; Insomnia; Depression; Anxiety; Substance use disorders

Funding

  1. NIH
  2. Sanofi-Aventis
  3. Cephalon
  4. GlaxoSmithKline
  5. Merck
  6. Neurocrine
  7. Pfizer
  8. Sunovion/Sepracor
  9. Somaxon
  10. Takeda
  11. Transcept
  12. Phillips-Respironics
  13. Neurogen
  14. Evotec
  15. Kingsdown Inc
  16. Astellas
  17. Abbott

Ask authors/readers for more resources

There is growing experimental evidence that the relationship between psychiatric disorders and sleep is complex and includes bidirectional causation. This article provides the evidence that supports this point of view, reviewing data on sleep disturbances seen in patients with psychiatric disorders as well as data on the impact of sleep disturbances on psychiatric conditions. Although much has been learned about the psychiatric disorders sleep relationship, additional research is needed to better understand the relationship. Such work promises to improve comprehension of these phenomena and lead to better treatment for the many patients with sleep disorders and psychiatric disorders.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available